ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Recruiting

AdstiladrinADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Sponsor:

Ferring Pharmaceuticals

Code:

NCT06026332

Conditions

Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ADSTILADRIN

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-03. This information was provided to ClinicalTrials.gov by Ferring Pharmaceuticals on 2024-11-13.